1. Home
  2. GRFS vs FRSH Comparison

GRFS vs FRSH Comparison

Compare GRFS & FRSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRFS
  • FRSH
  • Stock Information
  • Founded
  • GRFS 1940
  • FRSH 2010
  • Country
  • GRFS Spain
  • FRSH United States
  • Employees
  • GRFS N/A
  • FRSH N/A
  • Industry
  • GRFS Biotechnology: Pharmaceutical Preparations
  • FRSH EDP Services
  • Sector
  • GRFS Health Care
  • FRSH Technology
  • Exchange
  • GRFS Nasdaq
  • FRSH Nasdaq
  • Market Cap
  • GRFS 6.0B
  • FRSH 5.0B
  • IPO Year
  • GRFS 2006
  • FRSH 2021
  • Fundamental
  • Price
  • GRFS $9.45
  • FRSH $15.73
  • Analyst Decision
  • GRFS Sell
  • FRSH Buy
  • Analyst Count
  • GRFS 2
  • FRSH 13
  • Target Price
  • GRFS $10.50
  • FRSH $18.69
  • AVG Volume (30 Days)
  • GRFS 1.0M
  • FRSH 5.1M
  • Earning Date
  • GRFS 01-01-0001
  • FRSH 11-06-2024
  • Dividend Yield
  • GRFS N/A
  • FRSH N/A
  • EPS Growth
  • GRFS N/A
  • FRSH N/A
  • EPS
  • GRFS 0.27
  • FRSH N/A
  • Revenue
  • GRFS $7,814,096,584.00
  • FRSH $685,960,000.00
  • Revenue This Year
  • GRFS $8.86
  • FRSH $22.23
  • Revenue Next Year
  • GRFS $7.00
  • FRSH $14.41
  • P/E Ratio
  • GRFS $41.33
  • FRSH N/A
  • Revenue Growth
  • GRFS 7.21
  • FRSH 20.45
  • 52 Week Low
  • GRFS $5.30
  • FRSH $10.81
  • 52 Week High
  • GRFS $12.15
  • FRSH $24.98
  • Technical
  • Relative Strength Index (RSI)
  • GRFS 62.73
  • FRSH 71.27
  • Support Level
  • GRFS $8.69
  • FRSH $16.08
  • Resistance Level
  • GRFS $9.75
  • FRSH $17.05
  • Average True Range (ATR)
  • GRFS 0.37
  • FRSH 0.55
  • MACD
  • GRFS 0.06
  • FRSH 0.34
  • Stochastic Oscillator
  • GRFS 80.27
  • FRSH 75.85

About GRFS Grifols S.A.

As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies.

About FRSH Freshworks Inc.

Freshworks Inc provides software as a service platform that enables small and medium-sized businesses to support customers through e-mail, phone, website, and social networks. It offers solutions that serve the needs of users in the CS and ITSM categories and has also expanded its offering with Sales and Marketing automation products. These product offerings enable organizations to acquire, engage, and serve their customers and employees. The group derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and Other regions.

Share on Social Networks: